SAM #140D0426Q0207

Procurement of Oxford Nanopore PromethION 2 Integrated Sequencing Platform for Cancer Research

This procurement opportunity is for the National Cancer Institute's Center for Cancer Research to acquire advanced genomic sequencing technology. - Government Buyer: - Department of the Interior, Interior Business Center, Acquisition Services Directorate, Division 3, Branch 3 (on behalf of NIH National Cancer Institute) - OEM Highlight: - Oxford Nanopore Technologies, Inc. is the sole OEM specified - Products/Services Requested: - One (1) Oxford Nanopore PromethION 2 Integrated (P2i) Long-read Sequencing Platform - Part number: PromethION 2 Integrated - Includes installation, calibration, warranty support, and required training - Features onboard CPU/GPU acceleration, Dorado base calling, modified base detection, demultiplexing, and downstream analysis - Compatible with existing PromethION flow cells and validated CCR workflows - Unique/Notable Requirements: - Sole-source justification based on compatibility with existing workflows and equipment - Delivery and installation required within four to twelve weeks after award - Platform is essential for advanced cancer genomics research at the CCR Genomics Core, National Cancer Institute

Description

The Department of the Interior, Interior Business Center (AQD), intends to issue a sole-source award to Oxford Nanopore Technologies, Inc. for one PromethION 2 Integrated (P2i) long-read sequencing platform, including installation, calibration, training, and standard warranty support. The P2i integrates onboard CPU/GPU acceleration for real-time sequencing control, Dorado base calling, modified base detection, demultiplexing, and downstream analysis, and is fully compatible with existing PromethION flow cells and validated CCR workflows.Place of delivery and installation:CCR Genomics Core, National Cancer Institute37 Convent Drive, MSC 4256Bethesda, MD 20892-4256Required time of delivery:Within four (4) to twelve (12) weeks after award.NAICS: 334516 | PSC: 6632Authority: RFO 6.103-1; Procedures: RFO 12.201-1

View original listing